GRP
SRPT icon

Global Retirement Partners’s Sarepta Therapeutics SRPT Stock Holding History

Global Retirement Partners’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
+610
New +$11.5K ﹤0.01% 3343
2025
Q4 		$839 Buy
39
+11
+39% +$232 ﹤0.01% 3912
2025
Q3 		$540 Sell
28
-26
-48% -$464 ﹤0.01% 3633
2025
Q2 		$923 Buy
+54
New +$2.3K ﹤0.01% 3462
2024
Q4 		$15.7K Buy
129
+10
+8% +$1.23K ﹤0.01% 2207
2024
Q3 		$14.9K Hold
119
– – ﹤0.01% 2138
2024
Q2 		$18.8K Buy
119
+58
+95% +$7.45K ﹤0.01% 2015
2024
Q1 		$7.9K Buy
61
+13
+27% +$1.59K ﹤0.01% 2219
2023
Q4 		$5.54K Sell
48
-33
-41% -$3.17K ﹤0.01% 2283
2023
Q3 		$9.54K Buy
81
+5
+7% +$565 ﹤0.01% 1975
2023
Q2 		$8.7K Hold
76
– – ﹤0.01% 2008
2023
Q1 		$9.53K Buy
+76
New +$9.86K ﹤0.01% 1946
2021
Q1 		– Sell
-5
Closed -$1K – 1889
2020
Q4 		$1K Hold
5
– – ﹤0.01% 1698
2020
Q3 		$1K Sell
5
-1
-17% -$152 ﹤0.01% 1586
2020
Q2 		$1K Hold
6
– – ﹤0.01% 1563
2020
Q1 		$1K Hold
6
– – ﹤0.01% 1523
2019
Q4 		$1K Sell
6
-1,785
-100% -$180K ﹤0.01% 1565
2019
Q3 		$135K Buy
1,791
+1,777
+12,693% +$210K 0.02% 429
2019
Q2 		$2K Buy
+14
New +$1.7K ﹤0.01% 1457

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Global Retirement Partners's SRPT Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 610 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #3343 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in SRPT as recently as Q4 2025.

Global Retirement Partners first reported a position in SRPT in Q2 2019 and has held it in 19 quarters since. The position peaked at $135K in Q3 2019. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Global Retirement Partners held 610 shares of Sarepta Therapeutics worth $11K as of Q2 2026.
  • Sarepta Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3343 holding.
  • Global Retirement Partners first reported a position in Sarepta Therapeutics in Q2 2019 and has held it in 19 quarters since.
  • Global Retirement Partners's Sarepta Therapeutics position peaked at $135K in Q3 2019.
  • 324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.